181 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
ACAD ACADIA Pharmaceuticals Inc. $14.06 $1.76B Uptrend
Article Searches
Acadia's Big Scores https://seekingalpha.com/article/4208643-acadias-big-scores?source=feed_sector_healthcare Sep 27, 2018 - Acadia is pretty much a one-therapy company under development for a variety of critical applications.The one FDA-approved indication for Acadia's key therapy, NUPLAZID (pimavanserin), has been under s
Biotech Stock Roundup: ALXN Soliris Successful, Respite For Sarepta, AMRN Soars http://www.zacks.com/stock/news/324916/biotech-stock-roundup-alxn-soliris-successful-respite-for-sarepta-amrn-soars?cid=CS-ZC-FT-324916 Sep 26, 2018 - Data read-outs by quite a few companies grabbed headlines in the biotech sector this week.
Own A Bond Instead Of Ford - Cramer's Lightning Round (8/22/18) https://seekingalpha.com/article/4201398-bond-instead-ford-cramers-lightning-round-8-22-18?source=feed_tag_cramers_picks Aug 23, 2018 - Dropbox has a great business model.Amgen is cheap compared to Acadia Pharmaceuticals.XPO Logistics is a buy.
Acadia: Nuplazid Troubles Boost Roluperidone Prospects https://seekingalpha.com/article/4197976-acadia-nuplazid-troubles-boost-roluperidone-prospects?source=feed_sector_healthcare Aug 11, 2018 - Possible future competitor to Minerva, Acadia reported decreasing growth visibility and uptake for their drug, Nuplazid.This is likely attributed to recent and relevant safety concerns raised surround
After-Hours Report: SAIL +11.6%, YELP +10.9%, CVNA +10%, ELF -10.2%, ACAD -9.1% on earnings/guidance http://www.briefing.com/investor/popuppages/articlepopup.aspx?articleId=NS20180808171158AfterHoursReport Aug 08, 2018 - The S&P 500 finished Wednesday slightly lower, ending its four-session winning streak with an uneven
Playing The Expectations Game In Biotech https://seekingalpha.com/article/4187892-playing-expectations-game-biotech?source=feed_all_articles Jul 17, 2018 - The biotechnology sector is fertile ground for highly profitable investments, but the downside risk in the sector is also above average.Since the dispersion in returns is so wide, picking the right in
Better Buy: Acadia Pharmaceuticals vs. Eli Lilly https://www.fool.com/investing/2018/07/13/better-buy-acadia-pharmaceuticals-vs-eli-lilly.aspx?source=iedfolrf0000001 Jul 13, 2018 - Which stock wins in a battle between a small, beaten-down biotech and an established major drugmaker?
Dopamine and the Weather, Part 2 http://www.zacks.com/stock/news/311347/dopamine-and-the-weather-part-2?cid=CS-ZC-FT-311347 Jul 12, 2018 - How technology changes human behavior and social rules, but not human nature and genetics???yet.
Steven Cohen Powers Into C&J Energy Services http://www.gurufocus.com/news/706683/steven-cohen-powers-into-cj-energy-services Jul 11, 2018 - Steven Cohen Powers Into C&J Energy Services, Stocks: CJ,CBIO,PAGS,ACAD, Steven Cohen, release date:Jul 11, 2018
3 Stocks Move Monday http://www.gurufocus.com/news/705433/3-stocks-move-monday Jul 09, 2018 - 3 Stocks Move Monday, Stocks: ACAD,DLPH,PFE, release date:Jul 09, 2018

Pages: 123456...19

Page 1>

Related Companies

Name Exchange Price Mkt Cap
PAHC Phibro Animal Health Corporation NASDAQ $43.3 $1.75B
MRTX Mirati Therapeutics, Inc. NASDAQ $54.75 $1.77B
ENTA Enanta Pharmaceuticals, Inc. NASDAQ $91.79 $1.78B
ZGNX Zogenix, Inc. NASDAQ $48.55 $1.74B
CORT Corcept Therapeutics Incorporated NASDAQ $14.74 $1.71B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for ACADIA Pharmaceuticals